title: Dapagliflozin propanediol, avanafil, and conjugated estrogens/bazedoxifene.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Purzycki
mesh_terms: D001559:Benzhydryl Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects / Q000627:therapeutic use*; D005960:Glucosides / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D011409:Propylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D001559:Benzhydryl Compounds; D004966:Estrogens, Conjugated (USP); D005960:Glucosides; D007211:Indoles; D011409:Propylene Glycols; D011743:Pyrimidines; D020845:Selective Estrogen Receptor Modulators; C529054:dapagliflozin; C553414:avanafil; C447119:bazedoxifene